Researchers at the University of Cologne’s CECAD Cluster of Excellence for Aging Research and the CEPLAS Cluster of Excellence for Plant Sciences have found a promising synthetic plant biology approach for the development of a therapy to treat human neurodegenerative diseases, especially Huntington’s disease. In their publication “In-planta expression of human polyQ-expanded huntingtin fragment reveals mechanisms to prevent disease-related protein aggregation” in Nature Aging, they showed that a synthetic enzyme derived from plants – stromal processing peptidase (SPP) – reduces the clumping of proteins responsible for the pathological changes in models of Huntington’s disease in human cells and the nematode Caenorhabditis elegans.
Huntington’s disease is among the so called polyglutamine (polyQ) diseases, a group of neurodegenerative disorders caused by multiple repetitions of glutamine amino acids in specific proteins. An excessive number of polyQ repeats can cause proteins to aggregate or accumulate in harmful and damaging protein deposits, leading to cellular dysfunction and death. To date, nine polyQ disorders have been described in humans. They all remain incurable. Among them, Huntington’s disease is an inherited condition that causes widespread deterioration in the brain and disrupts thinking, behavior, emotion and movement.
Plants are immune to harmful protein aggregation
In their recent study, Professor Dr David Vilchez (CECAD) and Dr Ernesto Llamas (CEPLAS) followed an unconventional approach to find potential drugs to treat polyQ diseases like Huntington’s. Plants are constantly challenged by the environment, but they cannot move to escape from these conditions. However, plants possess a striking resilience to stress that allows them to live long. Unlike humans who suffer from proteinopathies caused by the toxic aggregation or cluster of proteins, plants do not experience these kinds of diseases. They express hundreds of proteins containing polyQ repeats, but no pathologies from these factors have been reported. To explore how plants deal with toxic protein aggregation, Dr Ernesto Llamas, first author of the study, and colleagues introduced the toxic mutant protein huntingtin in plants, which causes cell death in human neurons. In contrast to animal and human models, they found that Arabidopsis thaliana plants actively removed huntingtin protein clumps and avoid harmful effects.
By means of synthetic biology, the scientists then transferred the plants’ ability to avoid aggregation into human cultivated cells and animal models of Huntington’s disease. Their hope is that the use of plant proteins could lead to new therapeutic approaches for treating Huntington’s disease and other neurodegenerative diseases.
“We were surprised to see plants completely healthy, even though they were genetically producing the toxic human protein. The expression of mutant huntingtin in other models of research like human cultured cells, mice and nematode worms induce detrimental effects and symptoms of disease,” said David Vilchez.
Plant protein alleviates symptoms in human cells and nematodes
The next step was to discover how plants avoided the toxic aggregation of mutant huntingtin. Indeed, the scientists discovered that the chloroplasts, the plant-specific organelles that perform photosynthesis, were the reason why plants do not show toxic protein deposits. Llamas said: “Unlike humans, plants have chloroplasts, an extra cellular type of organelle that could provide an expanded molecular machinery to get rid of toxic protein aggregates.”
The multidisciplinary team identified the chloroplast plant protein SPP as the reason why plants are unaffected by the problematic human protein. Producing the plant SPP in models of Huntington’s disease such as human cultured cells and worms like the nematode C. elegans reduced protein clumps and symptoms of disease. “We were pleased to observe that expression of the plant SPP protein improved motility of C. elegans worms affected by huntingtin even at later aging stages where the symptoms are even worse,” said Dr Hyun Ju Lee, a postdoc also involved in the study. The results thus open the door to testing SPP as a potential therapy for Huntington’s disease.
Plants as models for aging research
Llamas is convinced that plant research can make a meaningful contribution to treating human diseases. “Many people don’t notice that plants can persist amongst variable and extreme environmental conditions that cause protein aggregation. I believe that plant molecular mechanisms hold the key to discovering new drugs that can prevent human diseases. We usually forget that some plants can live thousands of years and should be studied as models of aging research.” Dr Seda Koyuncu, another postdoc involved in the study, added: “Over the past years, we have seen several promising approaches to treating hereditary diseases like Huntington’s fail. We are confident that our plant synthetic approach will lead to significant advances in the field.”
The team has since acquired funding form the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung – BMBF) through the GO-Bio initial program. “We want to bring our idea into an application. Our plan is to found a start-up to produce plant-derived therapeutic proteins and to test them as potential therapeutics to treat neurodegenerative diseases in humans,” said Llamas.
The research was conducted at the University of Cologne’s CECAD Cluster of Excellence in Aging Research and CEPLAS Cluster of Excellence on Plant Sciences.
CONTAGIOUS CANCERS IN COCKLES SEQUENCED, SHOWING UNEXPECTED INSTABILITY
Transmissible cancers in cockles — marine cancers that can spread through the water — have been sequenced for the first time, unearthing new insight into how these cancers have spread across animal populations for hundreds, possibly thousands, of years.
The study, from researchers at the Wellcome Sanger Institute, the CiMUS research centre at the Universidade de Santiago de Compostela in Spain, and collaborators across multiple countries, found that these cockle tumours are highly genetically unstable. The cancer ...
Observations of the BlueWalker 3 prototype satellite show it is one of the brightest objects in the night sky, outshining all but the brightest stars.
Astronomers have raised concerns that without mitigation, groups of large satellites could disrupt our ability to observe the stars from Earth and perform radio astronomy.
Several companies are planning ‘constellations’ of satellites – groups of potentially hundreds of satellites that can deliver mobile or broadband services anywhere in the world.
However, these satellites need to be in ‘low-Earth’ orbit and can be relatively large, ...
When two, three or four apples are placed in front of us, we are able to recognize the number of apples very quickly. However, we need significantly more time if there are five or more apples and we often also guess the wrong number. In fact, the brain does actually register smaller numbers of things differently than larger ones. This has been demonstrated in a recent study by the University of Tübingen, University of Bonn and the University Hospital Bonn. The results were published in the magazine Nature ...
In a groundbreaking study published in JAMA Pediatrics on October 2, 2023, researchers at Boston Children’s Hospital shed new light on the evolving nature of Autism Spectrum Disorder (ASD) diagnoses in early childhood. Diagnosing ASD at a young age is important for early intervention and treatment, but this new study suggests that not all kids continue to meet the criteria for ASD as they get older.
The team found that 37% of children diagnosed with ASD as toddlers no longer meet the criteria for ASD around the age of six. Children with lower adaptive skills—essential everyday abilities encompassing communication, self-care, and decision-making—tend ...
Unfortunately, precisely in these rural densely populated Asian regions, mangroves have in the past been cleared to free up land for other uses such as aquaculture. This has made these coasts vulnerable to rapid erosion. Restoring mangroves seems a logical solution to reverse this process and protect these densely populated coastlines. However, this requires understanding if mangroves can cope with extreme rates of relative sea level rises, as experienced in these subsiding areas.
Since 2015 NIOZ researcher Celine van Bijsterveldt visited Indonesia regularly during her studies and her Phd. ...
Using a new analysis method for satellite images, an international research team, coordinated by the French Alternative Energies and Atomic Energy Commission (CEA) and INRAE, mapped for the first time annual changes in global forest biomass between 2010 and 2019. Researchers discovered that boreal and temperate forests have become the main global carbon sinks. Tropical forests, which are older and degraded by deforestation, fire and drought, are nearly carbon neutral. The findings, published in Nature Geoscience, highlight the importance of accounting for young forests and forest ...
Subarachnoid haemorrhage (SAH) is one of the most dangerous cerebrovascular disorders, with as many as 40% of patients dying within one month of the event.
A study recently published in the esteemed Neurology journal investigated whether there are differences in the prognosis of SAH patients between the university hospital districts in Finland. The research dataset was composed of nearly 10,000 SAH cases from 1998 to 2017, including information on patients who died before receiving neurosurgical care.
Mobile phones, smartwatches and earbuds are some gadgets that we carry around physically without much thought. The increasingly digitalised world sees a shrinking gap between human and technology, and many researchers and companies are interested in how technology can be further integrated into our lives.
What if, instead of incorporating technology into our physical world, we assimilate ourselves into a virtual environment? This is what Assistant Professor Xiong Zehui from the Singapore University of Technology ...
The research teams of Professor René Ketting at the Institute of Molecular Biology (IMB) in Mainz, Germany, and Dr. Sebastian Falk at the Max Perutz Labs in Vienna, Austria, have identified a new enzyme called PUCH, which plays a key role in preventing the spread of parasitic DNA in our genomes. These findings may reveal new insights into how our bodies detect and fight bacteria and viruses to prevent infections.
Our cells are under constant attack from millions of foreign intruders, such as viruses and bacteria. To keep us from getting sick, ...
UVA Health researchers have developed a powerful new tool to understand how medications affect men and women differently, and that will help lead to safer, more effective drugs in the future.
Women are known to suffer a disproportionate number of liver problems from medications. At the same time, they are typically underrepresented in drug testing. To address this, the UVA scientists have developed sophisticated computer simulations of male and female livers and used them to reveal sex-specific differences in how the tissues are affected by drugs.
The new model has already provided ...